Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 10—October 2023
Research

Candida auris Clinical Isolates Associated with Outbreak in Neonatal Unit of Tertiary Academic Hospital, South Africa

Dikeledi Kekana, Serisha D. Naicker, Liliwe Shuping, Sithembiso Velaphi, Firdose L. Nakwa, Jeannette Wadula, Nelesh P. GovenderComments to Author , and for GERMS-SA1
Author affiliations: National Institute for Communicable Diseases, Johannesburg, South Africa (D. Kekana, S.D. Naicker, L. Shuping, N.P. Govender); University of the Witwatersrand, Johannesburg (D. Kekana, S. Velaphi, F.L. Nakwa, J. Wadula, N.P. Govender); Chris Hani Baragwanath Academic Hospital, Johannesburg (S. Velaphi, F.L. Nakwa, J. Wadula); University of Cape Town, Cape Town, South Africa (N.P. Govender); University of Exeter, Exeter, United Kingdom (N.P. Govender)

Main Article

Table 3

Clade proportions and frequency of antifungal drug resistance within the study population among 188 Candida auris isolates, South Africa

Clade No. (%) isolates
All Fluconazole resistant Point mutation in ERG11 Point mutation in FKS1 Amphotericin B resistant
III
 118 (62.5)
 117 (99.1)
 118 (100)
 0
 2 (2.8)
IV 70 (37.4) 66 (91.4) 70 (100) 0 1 (1.42)

Main Article

1Members of GERMS-SA are listed at the end of this article.

Page created: August 31, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external